Genzyme Patents

Patent portfolio assigned to Genzyme (verified via public assignee records). Genzyme (now Sanofi Genzyme), rare-disease / enzyme-replacement biotech (acquired by Sanofi 2011). Large patent portfolio under assignee 'Genzyme Corporation' on Google Patents (e.g. US5549892A glucocerebrosidase, US10429288B2). B2B/clinical - no named customers.